Pharmaceuticals

Kinex Completes Acquisition of QuaDPharma

NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., aWestern New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and bio...

2014-09-09 23:40 1942

CPhI Korea 2014 Ends with a Great Success!

SEOUL, South Korea, Sept. 8, 2014 /PRNewswire/ -- CPhI Korea 2014, organized by the leading events organiser UBM and Korea Pharmaceutical exhibition, was held at Coex from 2nd to 3rd of September. In the welcome luncheon on 2nd of September, Joung Kyu Lee, chairman of Korea Pharmaceutical Trader...

2014-09-08 20:55 1412

Frost & Sullivan Recognizes DSM Biomedical's Outstanding Growth as a 'Total Solutions' Provider in the Medical Device Coatings Market

MOUNTAIN VIEW, Calif., Sept. 8, 2014 /PRNewswire/ -- Based on its recent analysis of the medical device coatings market, Frost & Sullivan recognizes DSM Biomedical with the 2014 North America Frost & Sullivan Award for Growth Excellence Leadership. DSM Biomedical is a total solutions provider tha...

2014-09-08 20:00 1248

New Platforms Enhance AMRI's Discovery Biology Offerings

ALBANY, N.Y., Sept. 4, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of ...

2014-09-04 20:00 1055

First Tele-health Programme for Heart Failure Patients in Singapore Enables Patients to Better Manage their Health and Reduce Hospitalisation

SINGAPORE, Sept. 4, 2014 /PRNewswire/ -- The Eastern Health Alliance (EH Alliance) and Changi General Hospital (CGH) have partnered Philips Healthcare (Philips) to pilotSingapore's first tele-health programme for heart failure patients inSingapore. The innovative programme integrates three key...

2014-09-04 17:14 1771

New Data Presented at WCCS Confirm High Long-term Efficacy of Picato® in Patients with Actinic Keratosis

BALLERUP, Denmark, Sept. 4, 2014 /PRNewswire/ -- Not for US media The digital press release with multimedia content can be accessed here: http://www.multivu.com/players/uk/7276254-WCCS-Picato-actinickeratosis/ New data f...

2014-09-04 14:00 1445

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

DARMSTADT, Germany, Sept. 3, 2014 /PRNewswire/ -- Not intended for UK based media * Detailed 26-week results of SPARK study presented at SSIEM Annual Symposium  * Phenylalanine tolerance significantly increased in children with PKU below 4 years of age, previously shown to be responsive to Ku...

2014-09-03 21:33 1427

Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014

HONG KONG, Aug. 30, 2014 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd.("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both ph...

2014-08-30 00:07 2092

Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

OSAKA, Japan, Aug. 29, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities includingthe United States (U.S.) Food and Drug Adminis...

2014-08-29 01:16 1870

CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years

FRANKFURT AM MAIN, Germany, Aug. 29, 2014 /PRNewswire/ -- The CAIDE Dementia Risk App from Merz Pharmaceuticals is available free of charge for people from 40 to 65 to calculate their individual risk for getting dementia within the next two decades. Using a traffic light color scheme, the App can...

2014-08-29 00:24 1659

CPhI & P-MEC China 2014 Event Achieved its Grand Closing

SHANGHAI, Aug. 26, 2014 /PRNewswire/ -- CPhI, ICSE & BioPh China 2014 and P-MEC, InnoPack & LABWorld China 2014, held on 26th -28th of June hosted by UBM Live and CCCMHPIE and co-organized by UBM Sinoexpo, achieved its successful close at Shanghai New International Expo Centre.

2014-08-26 09:00 1742

ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection

LONDON, Aug. 23, 2014 /PRNewswire/ -- ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.1 Triumeq is ViiV Healthcare's first dolutegravir-based ...

2014-08-23 04:17 3694

Amerigen Pharmaceuticals Ltd. Announces that its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has Received Chinese FDA (CFDA) Approval and has Subsequently Launched its Generic Mecobalamin 0.5 mg Tablets into the China Domestic Market

LYNDHURST, N.J., Aug. 20, 2014 /PRNewswire/ -- Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into theChina domestic market...

2014-08-20 21:37 2089

Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study

REDWOOD CITY, California, Aug. 15, 2014  /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study that compared CHS-1420 to Humira® in ...

2014-08-15 06:33 2344

Mundipharma Announces Principal Partner Sponsorship for Singapore's National Day Parade 2014

SINGAPORE, Aug. 7, 2014 /PRNewswire/ -- Mundipharma, one of the fastest growing pharmaceutical companies in the region, announced today its status as principal partner of this year's National Day Parade (NDP)  -- the first time ever for a pharmaceutical company to hold this position. In celebrati...

2014-08-07 09:00 2333

Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry

MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- Based on its recent analysis of the stem cell tools and technologies industry, Frost & Sullivan recognizes Vitro Biopharma with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Vitro Biopharma has excelled i...

2014-08-05 20:46 1199

A Shot of Good Health : CRY India's Immunization Campaign

SINGAPORE, July 30, 2014 /PRNewswire/ -- Gopika was born against all the odds in an area ofIndia where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost care in her health and development...

2014-07-30 20:37 1426

Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform

LONDON, July 29, 2014 /PRNewswire/ -- Today, Frost & Sullivan recognizes Validic with the 2014 Global Frost & Sullivan Best Practices Award for Customer Value Leadership. The Validic mHealth interoperability solution is a cloud-based platform that connects digital health application developers, ...

2014-07-29 21:00 1157

A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market

MOUNTAIN VIEW, California, July 29, 2014 /PRNewswire/ -- Drug development for hepatitis C virus (HCV) antivirals has amplified with rising incidence rates and the intense need for curative therapy in the absence of a preventative vaccine. Change is underway as the market moves away from p...

2014-07-29 19:55 1043

Arthur J. Tipton, Ph.D., Named President of Controlled Release Society

BIRMINGHAM, Ala., July 29, 2014 /PRNewswire/ -- Southern Research Institute today announced thatArthur J. Tipton, Ph.D., President and CEO of Southern Research Institute, has been named president of the Controlled Release Society (CRS) for the 2014-2015 term.  The inauguration took place at the S...

2014-07-29 00:14 1383
1 ... 96979899100101